|
Items/Page: Sort: |
| High-throughput screening for Weyl semimetals with S4 symmetry [期刊论文]
Science Bulletin, 2021-01-01, 66 (7
Gao J.; Qian Y.; Nie S.; Fang Z.; Weng H.; Wang Z.
 View/Download：8/0
|
| Bonding interface boosts the intrinsic activity and durability of NiSe@Fe2O3 heterogeneous electrocatalyst for water oxidation [期刊论文]
Science Bulletin, 2021-01-01, 66 (1
Guo K.; Wang Y.; Yang S.; Huang J.; Zou Z.; Pan H.; Shinde P.S.; Pan S.; Huang J.; Xu C.
View/Download：10/0
|
| Acidic pH transiently prevents the silencing of self-renewal and dampens microRNA function in embryonic stem cells [期刊论文]
Science Bulletin, 2021-01-01, 66 (13
Guo W.; Wang S.; Zhang X.; Shi M.; Duan F.; Hao J.; Gu K.; Quan L.; Wu Y.; Liang Z.; Wang Y.
View/Download：15/0
|
| SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chip [期刊论文]
Science Bulletin, 2021-01-01, 66 (8
Guo Y.; Luo R.; Wang Y.; Deng P.; Song T.; Zhang M.; Wang P.; Zhang X.; Cui K.; Tao T.; Li Z.; Chen W.; Zheng Y.; Qin J.
View/Download：19/0
|
| Corrigendum to “SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chip” [Sci. Bull. (2021) 66 (8) 783–793] (Science Bulletin (2021) 66(8) (783–793), (S2095927320307210), (10.1016/j.scib.2020.11.015)) [期刊论文]
Science Bulletin, 2021-01-01,
Guo Y.; Luo R.; Wang Y.; Deng P.; Song T.; Zhang M.; Wang P.; Zhang X.; Cui K.; Tao T.; Li Z.; Chen W.; Zheng Y.; Qin J.
View/Download：19/0
|
| Binding of the SARS-CoV-2 spike protein to glycans [期刊论文]
Science Bulletin, 2021-01-01, 66 (12
Hao W.; Ma B.; Li Z.; Wang X.; Gao X.; Li Y.; Qin B.; Shang S.; Cui S.; Tan Z.
View/Download：14/0
|
| Large-area atomic-smooth polyvinylidene fluoride Langmuir-Blodgett film exhibiting significantly improved ferroelectric and piezoelectric responses [期刊论文]
Science Bulletin, 2021-01-01, 66 (11
He S.; Guo M.; Dan Z.; Lan S.; Ren W.; Zhou L.; Wang Y.; Liang Y.; Zheng Y.; Pan J.; Shen Y.
View/Download：15/0
|
| Single-pixel imaging with neutrons [期刊论文]
Science Bulletin, 2021-01-01, 66 (2
He Y.-H.; Huang Y.-Y.; Zeng Z.-R.; Li Y.-F.; Tan J.-H.; Chen L.-M.; Wu L.-A.; Li M.-F.; Quan B.-G.; Wang S.-L.; Liang T.-J.
View/Download：15/0
|
| Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP) [期刊论文]
Science Bulletin, 2021-01-01, 66 (15
Ji L.; Song W.; Fang H.; Li W.; Geng J.; Wang Y.; Guo L.; Cai H.; Yang T.; Li H.; Yang G.; Li Q.; Liu K.; Li S.; Liu Y.; Shi F.; Li X.; Gao X.; Tian H.; Ji Q.; Su Q.; Zhou Z.; Wang W.; Zhou Z.; Li X.; Xu Y.; Ning Z.; Cao H.; Pan D.; Yao H.; Lu X.; Jia W.
View/Download：27/0
|
| Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS) [期刊论文]
Science Bulletin, 2021-01-01, 66 (15
Jia W.; Ma J.; Miao H.; Wang C.; Wang X.; Li Q.; Lu W.; Yang J.; Zhang L.; Yang J.; Wang G.; Zhang X.; Zhang M.; Sun L.; Yu X.; Du J.; Shi B.; Xiao C.; Zhu D.; Liu H.; Zhong L.; Xu C.; Xu Q.; Liang G.; Zhang Y.; Li G.; Gu M.; Liu J.; Yuan G.; Yan Z.; Yan D.; Ye S.; Zhang F.; Ning Z.; Cao H.; Pan D.; Yao H.; Lu X.; Ji L.
View/Download：33/0
|